Cellular therapy improves signs and symptoms of Duchenne muscular dystrophy
A recent clinical trial has shown that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
Why United and American Airlines Topped the Market Today
Several factors combined to provide investors a lift, particularly for United.
Home-based flu tests as accurate as rapid diagnostic testing in clinical settings
Home-based, self-administered tests for influenza are comparable in accuracy to rapid diagnostic tests in clinical settings, according to a peer-reviewed study. The researchers determined that sensitivity and specificity of the home test and clinical t…
Brain-based computing chips not just for AI anymore
With the insertion of a little math, researchers have shown that neuromorphic computers, which synthetically replicate the brain’s logic, can solve more complex problems than those posed by artificial intelligence and may even earn a place in high-perf…
Human induced pluripotent stem cells improve visual acuity, vascular health
Researchers are investigating novel regenerative medicine approaches to better manage vascular health complications from type 2 diabetes that could someday support blood vessel repair in the eye among diabetic patients with early retinal vascular dysfu…
Watershed size plays major role in filtering pollutants, researchers find
Research has found that watershed size plays a major role in a river network’s ability to do this work. The findings further the understanding of which estuaries and coastal areas will be more impacted by human development in their watersheds and also …
Antivirals, some antibodies, work well against BA.2 omicron variant of COVID-19 virus
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19, according to new research.
Scientists ‘supercharge’ cancer-fighting T cells
Scientists have identified a way to ‘supercharge’ tumor-attacking T cells, a finding that may not only improve the effectiveness of a promising type of cell-based cancer immunotherapy but also expand the number of cancers it can treat.